Dr. Alison Elizabeth Freeman, MD

Dr. Freeman practices at Northwest Endoscopy - Bellingham in Bellingham, Washington.

Dr. Freeman's NPI, 1235454091, was assigned on April 5, 2010. Dr. Freeman graduated from Rush Medical College of Rush University in 2010. Dr. Freeman holds Washington license MD61242402.

Dr. Freeman's primary practice is Northwest Endoscopy - Bellingham, at 3111 Woburn St, Suite 101, Bellingham, WA 98226. The practice phone is (360) 734-1420.

Dr. Freeman's primary practice is Northwest Endoscopy - Bellingham in Bellingham, Washington. Dr. Freeman is also affiliated with PeaceHealth St. Joseph Medical Center. The medical group on file is Northwest Gastroenterology & Endoscopy. Dmand AI also links Dr. Freeman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freeman practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Freeman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Freeman's licenses on file in 3 states: Washington, Colorado and Oregon.

CMS data shows 787 Medicare services from Dr. Freeman across 12 procedure codes in 2024, for 258 Medicare patients. Medicare paid $55,674 for them.

CMS counts 258 Medicare patients who saw Dr. Freeman in 2024. The largest group is 65 to 74, with 139 patients. 69% of them have high cholesterol, and 62% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freeman's median patient age at 57, with 61% women.

In 2024, Dr. Freeman wrote 424 Medicare Part D claims for 172 patients. 80% of them were for generic drugs. CMS names the drug for 310 of them, across 9 drugs with 11 or more claims each, at $20,279 in total drug cost. In 2023, CMS named 232 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Freeman for performance year 2024, reported as part of a group. Dr. Freeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freeman as offering telehealth. CMS counts 98 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Freeman, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Freeman in 2021. 2021 was the busiest year, with 2. The most frequent topics are Spondylitis, Ankylosing. Dr. Freeman's most frequent co-authors are Blair P. Fennimore, MD, Mark E. Gerich, MD and Emilie Helen Regner, MD.

Dmand AI links Dr. Freeman to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Clostridium Infections and Gram-Positive Bacterial Infections.

CMS Open Payments shows 52 general payments to Dr. Freeman from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. Covidien LP paid the most, $1,404.

Dr. Freeman graduated from Rush Medical College of Rush University in 2010.